Volume 26, Issue 4 pp. 495-502
ORIGINAL ARTICLE

Selective blockade of A2A receptor protects against neurotoxicity induced by kainic acid in young rats

Cristiani F. Bortolatto

Cristiani F. Bortolatto

Laboratório de Síntese, Reatividade e Avaliação Farmacológica e Toxicológica de Organocalcogênios, Centro de Ciências Naturais e Exatas, Universidade Federal de Santa Maria, Santa Maria, CEP 97105-900, RS, Brazil

Search for more papers by this author
Cristiano R. Jesse

Cristiano R. Jesse

Laboratório de Síntese, Reatividade e Avaliação Farmacológica e Toxicológica de Organocalcogênios, Centro de Ciências Naturais e Exatas, Universidade Federal de Santa Maria, Santa Maria, CEP 97105-900, RS, Brazil

Search for more papers by this author
Ethel A. Wilhelm

Ethel A. Wilhelm

Laboratório de Síntese, Reatividade e Avaliação Farmacológica e Toxicológica de Organocalcogênios, Centro de Ciências Naturais e Exatas, Universidade Federal de Santa Maria, Santa Maria, CEP 97105-900, RS, Brazil

Search for more papers by this author
Cristina W. Nogueira

Corresponding Author

Cristina W. Nogueira

Correspondence and reprints:
[email protected]Search for more papers by this author
First published: 01 June 2011
Citations: 1

Abstract

The aim of this study was to investigate the effect of SCH 58261, a selective adenosine A2A receptor (A2AR) antagonist, on kainic acid (KA)-induced seizures in 21-day-old rats. Rats were pretreated with SCH 58261 (1 or 3 mg/kg) by intraperitoneal (i.p.) route 30 min before KA (10 mg/kg, i.p.) administration. The appearance of clonic seizures, the latency for the onset of the first clonic seizure episode, and the number of deaths induced by KA were evaluated. To test the hypothesis of the oxidative imbalance induced by KA exposure, reactive species (RS) levels, catalase (CAT), glutathione peroxidase (GPx), and glutathione S-transferase (GST) activities in the brains of rats were measured. Both doses of SCH 58261 prolonged the latency for the onset of the first clonic seizure episode. SCH 58261, at the highest dose, decreased the appearance of clonic seizures as well as the mortality rate induced by KA administration. SCH 58261, at the dose of 3 mg/kg, was also effective in protecting against alterations in oxidative stress parameters (RS levels, CAT, GPx, and GST activities) in the brains of young rats exposed to KA. Our data reveal that SCH 58261 was protective against the neurotoxicity induced by KA. Therefore, the blockade of A2AR might represent a novel approach for the treatment of seizures.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.